उत्पाद वर्णन
XALIPAT 50 mg is a pharmaceutical tablet containing Lapatinib Ditosylate Monohydrate as the active ingredient. Specifically designed for adults diagnosed with HER2-positive breast cancer or other specified cancer conditions, this medication is recommended by healthcare professionals. Each box contains 10 tablets, with a dosage of 50 mg per tablet to be taken orally once daily before or after meals as directed. Store the tablets in a cool dry place away from direct sunlight and out of reach of children. The synthetic origin of the medicine ensures quality and efficacy in treating certain types of cancer, particularly HER2-positive tumors.